These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29064793)

  • 1. [Experience and comparison of antihypertensive effect of ace inhibitor spirapril and calcium antagonist amlodipinein standard and chronotherapeutic prescription mode].
    Ovchan HO; Khomenko VM; Andrushko II; Ostapchuk OI; Kyrychenko LM
    Wiad Lek; 2017; 70(4):721-724. PubMed ID: 29064793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension.
    Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison.
    Vreugdenhil G; van Montfrans GA; Jacobs MC; de Bruijn JH; Veerman DP; van Es PN; Mellein B; Guitard C; Thien T; de Leeuw PW
    Blood Press Suppl; 1994; 2():23-30. PubMed ID: 8061842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
    Shohat J; Wittenberg C; Erman A; Rosenfeld J; Boner G
    Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():77-80. PubMed ID: 15490771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the acute and chronic antihypertensive effect of two once-daily doses of spirapril by invasive twenty-four-hour ambulatory blood pressure monitoring.
    van den Meiracker AH; Man in 't Veld AJ; Ritsema van Eck HJ; Schalekamp MA
    J Hypertens Suppl; 1989 Dec; 7(6):S302-3. PubMed ID: 2561145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
    Guitard C; Sassano P; Tzincoca C; Duchiez J; Safar ME
    Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effect of spirapril and felodipine during repeated administration to spontaneously hypertensive rats.
    Monopoli A; Forlani A; Milani S; Ongini E
    Pharmacol Res Commun; 1988 Jan; 20(1):37-47. PubMed ID: 2836872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy.
    Haas M; Leko-Mohr Z; Erler C; Mayer G
    Am J Kidney Dis; 2002 Sep; 40(3):458-63. PubMed ID: 12200795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension.
    Noble S; Sorkin EM
    Drugs; 1995 May; 49(5):750-66. PubMed ID: 7601014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity.
    Manolis AJ; Beldekos D; Handanis S; Haralabidis G; Hatzissavas J; Foussas S; Cokkinos DV; Bresnahan M; Gavras I; Gavras H
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):640-8. PubMed ID: 9657622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.
    Hayduk K; Schardt F; Sierakowski B; Weidinger G; Welzel D
    Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advantages of long-term controlled stepwise therapy of arterial hypertension with the use of angiotensin converting enzyme inhibitor spirapril].
    Katel'nitskaia LI; Ivanchenko DN; Khansheva LA; Kholoshina LV; Glova SE; Pleskachev SA
    Kardiologiia; 2006; 46(3):35-8. PubMed ID: 16710253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of spirapril in mild-to-moderate hypertension.
    Hayduk K; Kraul H
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S19-23. PubMed ID: 10499560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE-inhibitor therapy with spirapril increases nocturnal hypotensive episodes in elderly hypertensive patients.
    Kantola I; Terént A; Kataja M; Breig-Asberg E
    J Hum Hypertens; 2001 Dec; 15(12):873-8. PubMed ID: 11773991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
    Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
    Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.